Jacqueline Ameri


Novo Nordisk Foundation Center for Stem Cell Biology, University of Copenhagen


The aim of our work is to produce GMP certified stem cell derived beta cells to initiate a phase 1 trial aiming to assess the safety of hPSC-derived beta cells. More specifically, this work entails GMP adaptation of our current differentiation protocol, screening of GMP cell lines, and the development of new strategies for expansion of pancreatic progenitors and their conversion into glucose-responsive beta cells.

Throughout my PhD training, postdoctoral research and my current work I have been focused on establishing strategies for differentiating hPSCs towards endoderm and pancreatic lineages, specifically beta cells.

© All rights reserved, Sciencenews 2020